652 related articles for article (PubMed ID: 19247977)
1. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
2. Primary CNS lymphoma.
Gerstner E; Batchelor T
Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system-directed preventative therapy in adults with lymphoma.
McMillan A
Br J Haematol; 2005 Oct; 131(1):13-21. PubMed ID: 16173958
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
6. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
[TBL] [Abstract][Full Text] [Related]
8. CNS prophylaxis in lymphoma: who to target and what therapy to use.
Hill QA; Owen RG
Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838
[TBL] [Abstract][Full Text] [Related]
9. Primary CNS lymphoma in immunocompetent patients.
Sierra del Rio M; Rousseau A; Soussain C; Ricard D; Hoang-Xuan K
Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: recent progress, many remaining questions.
Swinnen LJ
Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
[TBL] [Abstract][Full Text] [Related]
11. [Aggressive lymphomas].
Haioun C; Reyes F
Rev Prat; 2002 May; 52(9):972-7. PubMed ID: 12063763
[TBL] [Abstract][Full Text] [Related]
12. Treatment approaches for primary CNS lymphomas.
Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
[TBL] [Abstract][Full Text] [Related]
13. Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
Korfel A
Curr Opin Oncol; 2011 Sep; 23(5):436-40. PubMed ID: 21760506
[TBL] [Abstract][Full Text] [Related]
14. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities.
Wong ET
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7151s-7157s. PubMed ID: 16203815
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
Reni M; Ferreri AJ
Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
[TBL] [Abstract][Full Text] [Related]
17. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
Park BB; Kim JG; Sohn SK; Kang HJ; Lee SS; Eom HS; Kwon HC; Oh SY; Kang JH; Oh SJ; Shin HJ; Suh C; Kim JH; Kim HY; Kim K; Ryoo BY; Kim WS
Am J Hematol; 2007 Sep; 82(9):840-5. PubMed ID: 17563078
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
Bierman P; Giglio P
Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma.
Stern JI; Raizer JJ
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
[TBL] [Abstract][Full Text] [Related]
20. The risk of CNS involvement in aggressive lymphomas in the rituximab era.
Benevolo G; Chiappella A; Vitolo U
Expert Rev Hematol; 2013 Dec; 6(6):643-52. PubMed ID: 24168678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
